Epigenetics of Lupus

$46,707P30FY2011ARNIH

University Of Alabama At Birmingham, Birmingham AL

Investigators

Linked publications & trials

Paper 39451043 Paper 38570263 Paper 38183802 Paper 38108557 Paper 37981105 Paper 37919169 Paper 37717172 Paper 37604968 Paper 37365181 Paper 37283760 Paper 37256130 Paper 37046042 Paper 36958335 Paper 36907775 Paper 36775449 Paper 36345944 Paper 36315303 Paper 36239623 Paper 36189576 Paper 36165181 Paper 35907952 Paper 35644252 Paper 35562038 Paper 35454859 Paper 35436902 Paper 35307321 Paper 35300860 Paper 35272839 Paper 35178049 Paper 35110364 Paper 35041825 Paper 35002949 Paper 34907087 Paper 34890513 Paper 34827141 Paper 34725967 Paper 34586363 Paper 34545812 Paper 34521872 Paper 34516781 Paper 34301818 Paper 34289986 Paper 34274794 Paper 34180717 Paper 34158590 Paper 34076482 Paper 34038004 Paper 34023385 Paper 33864024 Paper 33779079 Paper 33690617 Paper 33559732 Paper 33559104 Paper 33543033 Paper 33490963 Paper 33411788 Paper 33405949 Paper 33311847 Paper 33310866 Paper 32889089 Paper 32859995 Paper 32795490 Paper 32776140 Paper 32737261 Paper 32636482 Paper 32610078 Paper 32554431 Paper 32456301 Paper 32122998 Paper 32049019 Paper 31988467 Paper 31953152 Paper 31944305 Paper 31821850 Paper 31631359 Paper 31620123 Paper 31574936 Paper 31562240 Paper 31547509 Paper 31519812 Paper 31491023 Paper 31434799 Paper 31398241 Paper 31356165 Paper 31270568 Paper 31231026 Paper 31173390 Paper 31076359 Paper 31035566 Paper 30948627 Paper 30939124 Paper 30910831 Paper 30833421 Paper 30810063 Paper 30646011 Paper 30642977 Paper 30412911 Paper 30373889 Paper 30334128 Paper 30286326

Abstract

SLE is a rheumatic disease characterized by production of auto-antibodies, systemic deposition of auto antibody immune complexes and subsequent tissue damage. It affects 1.5 million Americans and can lead to fatal complications such as kidney or heart failure. As a complex disease, with genetic and environmental risk factors, the analysis of epigenetic variation on the disease is likely to identify key genes that contribute to the disease, and this information could have both diagnostic and therapeutic benefits. Our proposal is designed to investigate the epigenetics of SLE with a small-scale pilot study that will tell us the extent to which DNA methylation contributes to SLE and identify which cell-types are needed for a careful analysis. The data will enable us to estimate the size of any epigenetic effects, so that we can construct well powered future studies to investigate other issues surrounding SLE, such as drug responses and ethnicity differences.

View original record on NIH RePORTER →